Page last updated: 2024-10-25

ciglitazone and Basophilic Leukemia, Acute

ciglitazone has been researched along with Basophilic Leukemia, Acute in 1 studies

ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lenman, A1
Fowler, CJ1

Other Studies

1 other study available for ciglitazone and Basophilic Leukemia, Acute

ArticleYear
Interaction of ligands for the peroxisome proliferator-activated receptor gamma with the endocannabinoid system.
    British journal of pharmacology, 2007, Volume: 151, Issue:8

    Topics: Amidohydrolases; Animals; Anti-Inflammatory Agents; Brain; Brain Neoplasms; Cannabinoid Receptor Mod

2007